Shriya is one in a million. For starters, shes a 9-year-old girl who will talk with anyone. Shes always upbeat and friendly, calling hello to everyone who walks by, even strangers.
Shes so brave, and shes such a chatterbox, says her father, Shyam.
Those are rare traits in a child, but what makes Shriya truly rare is having been born with Schimke immuno-osseous dysplasia (SIOD)a disease that affects just one in every million children in North America. Its fitting that Shriya was the recipient of Stanford Childrens Healths 1,000th stem cell transplantbeing the rare child that she is.
Shriya represents a new frontier of the stem cell transplantation field, so its incredibly exciting that she was our 1,000th stem cell patient, says Alice Bertaina, MD, PhD, section chief of the Pediatric Division of Stem Cell Transplantation and Regenerative Medicine and co-director of the Bass Center for Childhood Cancer and Blood Diseases at Lucile Packard Childrens Hospital Stanford.
SIOD affects multiple systems in the body, including the kidneys, heart, arteries, thyroid, lungs, nerves, and immune system. Children with SIOD are also short-statured. SIOD occurs when both the mother and father carry an abnormal gene.
When we first heard Shriya had SIOD, we couldnt believe it. At age 4, the only concern we had was her short height. We expected it to be fixed with growth hormones. Instead, we heard she had a rare, incurable disease, Shyam says.
Children with SIOD struggle with immune system problems and kidney disease that leads to kidney failure. All of this leaves a child fatigued and ill, including Shriya, who started experiencing kidney disease at the age of 5.
She could only run a few steps before getting tired, and she had to spend 14 hours a day on dialysis, Shyam says.
Shriyas parents were offered a stem cell transplant (also called a bone marrow transplant) in 2016 at another hospital, but at that time the odds of success, a mere 20%, were not worth the risk. By 2019, doctors at Stanford Childrens Health were investigating a much better option: a potential cure for their daughters rare disease.
Before we came to Stanford, all we could do was dream about a real treatment for Shriya. Stanford offered something that we never imagined would be possible, and its totally a dream come true, Shyam says.
Stanford Childrens Healths treatment for SIOD is a two-transplant approach that potentially eliminates the risk of rejection that comes with kidney transplantsand the anti-rejection drugs that accompany them. The game changer is the use of haploidentical stem cell transplant, which provides a child with a new immune system, followed by a kidney transplant from the same donor, usually a parent. Having one donor for both transplants dramatically lowers the risk of kidney rejection and the need for long-term immunosuppression.
With haploidentical stem cell transplants, we expand options for children who dont have a fully matched donor by using a partially matched donor, Dr. Bertaina says.
To make graft-versus-host disease (GvHD) even less likely, Dr. Bertainathe worldwide pioneer and foremost expert in alpha/beta T-cell depleted haploidentical stem cell transplantationselectively eliminates the immune systems cells (alpha/beta T cells) from the donor stem cells. She has been using this technique regularly to treat children with cancers and blood diseases, so applying it to SIOD patients was a new venture. Stanford Childrens Health has treated three SIOD patients with this method so farShriya and the Davenport siblings.
With the first SIOD patient it was almost an unthinkable idea, and now its a reality. We can offer children this chance at a cure, and thats very exciting, Dr. Bertaina adds.
Shriya received her stem cell transplant in January 2020 and her kidney transplant in the middle of the COVID-19 pandemic in July 2020. Both transplants went well.
The nice part of doing a bone marrow transplant first is that it makes the body think the kidney is her own, so the kidney could last a lifetime, says Amy Gallo, MD, surgical director of the pediatric kidney transplant program.
Traditionally, kidney transplants last only about 10 to 12 years because of the constant threat of rejection. Anti-rejection medicines help, but they come with the cost of side effects. By lessening the risk of rejection with this new, two-transplant approach, the hope is that children like Shriya can live beyond childhood and become adults, free from medicines and with functioning kidneys.
There have been multiple reports of kids with SIOD getting kidney transplants and dying because they could not tolerate the anti-rejection medicines. Thats why we decided to try something radically groundbreaking, says Paul Grimm, MD, medical director of the pediatric nephrology program.
Shriya went from taking 10 medicines right after her kidney transplant to taking none, today, Shyam says. Before the transplants, she had energy to climb only one set of stairs. Now, she runs up and down them all day long.
This unique, revolutionary approach to treating SIOD could be used to treat other incurable diseases, like cystinosis (a genetic disorder that affects multiple organs) and focal segmental glomerulosclerosis (FSGS), a type of kidney disease. Doctors at Stanford Childrens Health are exploring the possibilities.
SIOD is the first attempt at this two-transplant approach. We are very optimistic that it could be used for other rare, genetic diseases, but its so cutting-edge that we are moving ahead cautiously, Dr. Grimm says. Wouldnt it be wonderful if one day we could offer it to children with all types of kidney disease?
Shriyas body had difficulty detoxifying drugs, so her doctors were careful to give her just enough to condition her bone marrow to make room for the stem cell transplant. Dr. Grimm describes Dr. Bertaina as a chef tasting a stew to decide the perfect recipe for success.
We cannot say enough good things about Stanford. The doctors are like angels sent from heaven, says Shriyas mom, Rithula. We dont have family nearby, but the doctors and nurses were like a second family to us.
Historically, children with SIOD live to a mean age of 9. Shriya is breaking those odds and living a symptom-free life, today.
We have definitely improved her current quality of her life. Her energy is amazing, the way she runs around, Dr. Grimm says. We are hopeful that the stem cell transplant might cure the underlying disease.
There are a million things that Shriya wants to do. Thanks to this unique treatment approach for SIOD, she now has the energy to try them. First on her list was learning how to ride a scooter. Now, shes mastering riding a bike. After that, who knows? The possibilities are endlessjust like Shriyas love for life.
Learn more at kidneytransplant.stanfordchildrens.org >
Read the rest here:
- Drug Prototype Promising in Treatment of Pulmonary Disease - Medscape - April 20th, 2024
- Man Paralyzed In Surfing Accident Regains Ability to Walk After Stem Cell Treatment - The Inertia - April 20th, 2024
- Medical breakthrough: 8-year-old boy first in New York to receive FDA-approved gene therapy for rare inherited blood disorder - WABC-TV - April 20th, 2024
- Stem Cell Treatment Helped A Man Who Was Paralyzed From The Neck Down To Stand On His Own - Bored Panda - April 20th, 2024
- UM, CUHK jointly hold symposium on stem cells and regenerative medicine - gcs.gov.mo - April 20th, 2024
- Paralysed patient now able to walk as stem cell therapy shows promising results - WION - April 15th, 2024
- Andrew Steele Sees Aging as the Root of Disease - Worth - Worth Magazine - April 15th, 2024
- The astonishing effect of stem cell implants - as groundbreaking treatment 'transforms' life for those with brain damage ... - Daily Mail - April 15th, 2024
- Consumer Alert on Regenerative Medicine Products Including Stem Cells - FDA.gov - April 13th, 2024
- This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market - Forbes - April 13th, 2024
- Brain-cell transplants are the newest experimental epilepsy treatment - MIT Technology Review - April 3rd, 2024
- Global Regenerative Medicine Market to Touch Valuation of USD 472.95 Billion by 2032, at 25.86% CAGR: Astute ... - Yahoo Finance - April 1st, 2024
- Explosive Growth Projected for Stem Cell Market, Expected to Surpass $37 Billion by 2030 As Revealed In New... - WhaTech - April 1st, 2024
- Integrating New Therapies With Autologous Stem Cell Transplant in Myeloma - Targeted Oncology - April 1st, 2024
- New tool provides researchers with improved understanding of stem cell aging in the brain - Medical Xpress - March 30th, 2024
- The ISSCR announces 2024 election results - EurekAlert - March 28th, 2024
- Exosomes and Stem Cells Are the Future of Anti-Aging - NewBeauty Magazine - March 28th, 2024
- Charles River Extends Gene Therapy Alliance with NUS Medicine - Contract Pharma - March 22nd, 2024
- Exciting opportunities in stem cell technology and regenerative biology in Indian healthcare industry - Express Healthcare - March 22nd, 2024
- Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine - Yahoo Finance - March 22nd, 2024
- Opinion: The revolutionary sickle cell therapies - MSN - March 22nd, 2024
- 10 Years of Kansas Regenerative Medicine Center - KSAL - March 22nd, 2024
- BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership - Diagnostic and Interventional Cardiology - March 17th, 2024
- Cynata Therapeutics' breakthrough in regenerative medicine - Finance News Network - March 17th, 2024
- New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia - GlobeNewswire - March 17th, 2024
- Novel 3D stem cell therapy to treat critical limb ischaemia - Drug Target Review - March 15th, 2024
- Breaking Boundaries: Pharmicell's Bold Vision for Healthcare Transformation and Monumental Growth - The Worldfolio - March 15th, 2024
- CuSTOM Organoid Research Evolving From Tool to Treatment - Research Horizons - Research Horizons - March 15th, 2024
- BioCardia and StemCardia Announce Partnership to Deliver Cell-Gene Therapy for Remuscularization of Heart - Cath Lab Digest - March 15th, 2024
- Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine ... - Business Wire - March 13th, 2024
- Iron restriction keeps blood stem cells young, researchers find - Phys.org - March 13th, 2024
- Vitamin A could have a key role in both stem cell biology and wound healing: Study - Medical Dialogues - March 9th, 2024
- Trends in Stem Cell Transplantation Refusal for Myeloma Treatment - Targeted Oncology - March 7th, 2024
- Stem Cell Therapy Market (CAGR) of 31.1%, Future of Market Size Emerging Technologies and their Impact on ... - Taiwan News - March 7th, 2024
- This Swedish startup wants to reduce the cost, and controversy, around stem cell production - TechCrunch - March 6th, 2024
- Advancing stem cell therapy: The regulatory process to get to clinical trials - The Economic Times - March 6th, 2024
- Transitioning from traditional surgical methods to the innovative use of stem cells - pharmaphorum - March 6th, 2024
- 'Mini organs' are grown from human stem cells taken during the late stages of pregnancy for the first time - m - Daily Mail - March 6th, 2024
- Stem cell transplant cures man of HIV and leukemia, one of five to achieve full remission - Fox 28 - March 3rd, 2024
- Stem Cell Therapy Market to Boost USD 137.5 Billion by 2034 and Projected to grow at 32.10% CAGR with increasing ... - Yahoo Finance - March 1st, 2024
- Studies expand use of stem cell therapies - WPLG Local 10 - March 1st, 2024
- Innovative therapy targets and destroys leukemia stem cells - News-Medical.Net - February 27th, 2024
- Unlocking the Potential of Stem Cells: The Medical Revolution of the Century - EIN News - February 27th, 2024
- Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine ... - Yahoo Finance - February 27th, 2024
- Say Her Name - Henrietta Lacks, The Real Mother Of Stem - Her Campus - February 27th, 2024
- California Man Free of HIV And Cancer in Astonishing Medical Recovery - ScienceAlert - February 25th, 2024
- $93 million for research into improved health for children, young people and the aged, medical devices, mental health ... - Department of Health - February 25th, 2024
- Stem Cells in Regenerative Medicine - PMC - National Center for ... - February 24th, 2024
- The Promise and Reality of Stem Cell Therapy: What You Need to Know - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cell Therapy: A Beacon of Hope for Patients with Untreatable Conditions - Corporate Wellness Magazine - February 22nd, 2024
- Leading Experts in Stem Cell Therapy: A Global Overview - Corporate Wellness Magazine - February 22nd, 2024
- Can Stem Cells Help Reverse the Effects of Aging? - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cell Therapy for Cancer: Hope on the Horizon? - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cells and Autism: A Closer Look at Innovative Treatments - Corporate Wellness Magazine - February 22nd, 2024
- Regrowth and Restoration: The Science Behind Stem Cell Therapy for Hair - Corporate Wellness Magazine - February 22nd, 2024
- Brain Recovery: The Role of Stem Cells in Stroke and Cerebral Palsy Treatments - Corporate Wellness Magazine - February 22nd, 2024
- Turning Back the Clock: The Science of Stem Cells in Anti-Aging - Corporate Wellness Magazine - February 22nd, 2024
- Insights into cellular therapies for cancer treatment - Drug Target Review - February 22nd, 2024
- The Role of Stem Cells in Rheumatoid Arthritis Recovery - Corporate Wellness Magazine - February 22nd, 2024
- Dr Ernesto Romeros vision transforms immunotherapy regenerative medicine into a global leader in stem cell treatment - Khaleej Times - February 22nd, 2024
- World-Renowned Doctors Leading the Way in Stem Cell Research and Treatment - Medical Tourism Magazine - February 20th, 2024
- Choosing the Best: A Guide to America's Premier Stem Cell Therapy Providers - Medical Tourism Magazine - February 20th, 2024
- Navigating Through the Possibilities of Stem Cell Treatment for Eye Disorders - Medical Tourism Magazine - February 20th, 2024
- Global Leaders in Stem Cell Therapy: Where Excellence Meets Innovation - Medical Tourism Magazine - February 20th, 2024
- Excellence in Stem Cell Treatment: How the US is Pioneering Global Healthcare Solutions - Medical Tourism Magazine - February 20th, 2024
- Clarifying Memory Loss Treatments: The Role of Stem Cells - Medical Tourism Magazine - February 20th, 2024
- Battling Inflammation: Stem Cell Therapy for Rheumatoid Arthritis - Medical Tourism Magazine - February 20th, 2024
- Digestive Health and Stem Cells: Treating Ulcerative Colitis and Crohn's Disease - Medical Tourism Magazine - February 20th, 2024
- Top Stem Cell Clinics in the USA: Pioneering Treatments for Chronic Conditions - Medical Tourism Magazine - February 20th, 2024
- Stem Cells and Autism: Understanding the Potential for Innovative Treatments - Medical Tourism Magazine - February 20th, 2024
- Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse - University of Birmingham - February 20th, 2024
- City of Hope Achieves Ground Breaking Treatment for Blood Cancer and HIV - Medriva - February 18th, 2024
- Regenerative Medicine Market Size to Worth USD 95 Billion by 2032 - InvestorsObserver - February 18th, 2024
- North America Organoids Market Projected to Reach US$ 5.35 Billion by 2030, Riding on a CAGR of 21.5% - GlobeNewswire - February 18th, 2024
- Chinese team tests lung treatment that may be first to reverse COPD damage - South China Morning Post - February 15th, 2024
- Why leukemic stem cells not harmed by chemotherapy begin to grow and produce AML cells after treatment - Medical Xpress - February 15th, 2024
- Regenerative Medicine Market is Expected to Reach $49.0 Billion | MarketsandMarkets - Yahoo Finance - February 15th, 2024
- Study finds interleukin-24 enhances CAR-T cell therapy's effectiveness against cancer stem cells - News-Medical.Net - February 15th, 2024
- Oldest Patient 'Cured' of HIV Still in Remission 5 Years After Transplant for AML - Medpage Today - February 15th, 2024
- Drug used for cocaine addiction may pave way for new treatment of advanced colon cancer - EurekAlert - February 15th, 2024
Recent Comments